相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression
Xiaolei Li et al.
ONCOGENE (2021)
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
Kevin Chih-Yang Huang et al.
CANCERS (2020)
An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
Guan Wang et al.
NATURE COMMUNICATIONS (2020)
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
Alexandre Perrier et al.
BIOMOLECULES (2020)
Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
Ganjun Yu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Prognostic relevance of programmed cell death-ligand 1 expression and CD8+TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy
Tsung-Wei Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
Abdullah Al Emran et al.
TRENDS IN IMMUNOLOGY (2019)
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers
Shu-Fen Chiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
Goran Micevic et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
Na Luo et al.
NATURE COMMUNICATIONS (2018)
Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy
William L. Hwang et al.
JAMA ONCOLOGY (2018)
HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
Chih-Yang Huang et al.
CELL DEATH & DISEASE (2018)
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+T-cell infiltration in stage II-III colorectal cancer
Chih-Yang Huang et al.
SCIENTIFIC REPORTS (2018)
Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
Megha Budhwani et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting IFN alpha to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
Yong Liang et al.
NATURE COMMUNICATIONS (2018)
RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer
Xiangyu Wang et al.
BIOMEDICINE-TAIWAN (2018)
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Claire Vanpouille-Box et al.
CLINICAL CANCER RESEARCH (2018)
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia
D. Goltz et al.
LEUKEMIA (2017)
PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
Diane Goltz et al.
ONCOIMMUNOLOGY (2017)
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L. Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
Rui Zhou et al.
ONCOTARGET (2017)
RNA-Seq reveals seven promising candidate genes affecting the proportion of thick egg albumen in layer-type chickens
Yi Wan et al.
SCIENTIFIC REPORTS (2017)
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Zijun Y. Xu-Monette et al.
FRONTIERS IN IMMUNOLOGY (2017)
Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling
S. Goncalves-Ribeiro et al.
ANNALS OF ONCOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Heidrun Gevensleben et al.
ONCOTARGET (2016)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
Anna Diez-Villanueva et al.
EPIGENETICS & CHROMATIN (2015)
Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation
Tsung-Yao Lin et al.
BIOMEDICINE-TAIWAN (2015)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
Tobias Bald et al.
CANCER DISCOVERY (2014)
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
Raoul A. Droeser et al.
EUROPEAN JOURNAL OF CANCER (2013)
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
Jacob Piehler et al.
IMMUNOLOGICAL REVIEWS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
DNA Methylation Represses IFN-γ-Induced and Signal Transducer and Activator of Transcription 1-Mediated IFN Regulatory Factor 8 Activation in Colon Carcinoma Cells
Jon M. McGough et al.
MOLECULAR CANCER RESEARCH (2008)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
分享论文
